Radiopharmaceuticals/nuclear medicine market report gives comprehensive outlook on radiopharmaceuticals across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). The report on radiopharmaceuticals/nuclear medicine market gives historical, current, and future market sizes (US$ Mn) on the basis of product type, application area, route of administration, end user, and geographic regions. Global radiopharmaceuticals market estimated to be valued US$ 5,146 Mn in 2018 and poised to grow at CAGR of 8.9% over 2019-2025. Market for radiopharmaceuticals projected to reach US$ 8,564 Mn by 2025 owing to increasing adoption in radio therapeutic and diagnostic procedures across the globe.
Major Key Players of the Radiopharmaceuticals-Nuclear Medicine Market are:Advanced Accelerator Applications S.A. (France), Bayer AG (Germany), Bracco Imaging S.p.A (Italy), Cardinal Health, Inc. (U.S.), Eli Lilly and Co. (U.S.), GE Healthcare (U.S.), BA Molecular Imaging (Belgium), Jubilant Life Sciences Ltd (India), Lantheus Medical Imaging, Inc. (U.S.), Mallinckrodt plc (Ireland), Navidea Biopharmaceutical (U.S.), Nordion, Inc. (Canada), Siemens Healthineers (Germany)
Read More @ https://www.openpr.com/news/2049567/radiopharmaceuticals-nuclear-medicine-market-strategic-plan
Major Key Players of the Radiopharmaceuticals-Nuclear Medicine Market are:Advanced Accelerator Applications S.A. (France), Bayer AG (Germany), Bracco Imaging S.p.A (Italy), Cardinal Health, Inc. (U.S.), Eli Lilly and Co. (U.S.), GE Healthcare (U.S.), BA Molecular Imaging (Belgium), Jubilant Life Sciences Ltd (India), Lantheus Medical Imaging, Inc. (U.S.), Mallinckrodt plc (Ireland), Navidea Biopharmaceutical (U.S.), Nordion, Inc. (Canada), Siemens Healthineers (Germany)
Read More @ https://www.openpr.com/news/2049567/radiopharmaceuticals-nuclear-medicine-market-strategic-plan
No comments:
Post a Comment